Related Experiment Video
Updated: Jul 4, 2026

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Liver and cardiac function in the long term after Fontan operation
Sonia Camposilvan1, Ornella Milanesi, Giovanni Stellin
1Department of Pediatric Hepatology, University of Padova, Padova, Italy.
Long-term Fontan operation survivors often experience liver disease. Hepatic dysfunction correlates with low cardiac index, suggesting improved cardiac function may prevent liver issues.
Area of Science:
- Cardiology
- Hepatology
- Pediatric Cardiac Surgery
Background:
- Patients undergoing the Fontan operation are susceptible to developing liver disease.
- Long-term assessment of liver and cardiac function is crucial for Fontan survivors.
Purpose of the Study:
- To evaluate long-term liver and cardiac function in patients after Fontan operation.
- To identify correlations between hepatic dysfunction and hemodynamic parameters in this population.
Main Methods:
- Comprehensive assessment including physical examination, biochemical tests, echocardiography, and liver ultrasonography.
- Utilized a liver disease score to correlate liver involvement with hemodynamic features.
- Included 34 patients with a median follow-up of 11.5 years.
Main Results:
- High prevalence of liver abnormalities: hepatomegaly (53%), elevated gamma GT (61%), coagulopathy (58%).
- Hepatic dysfunction was significantly correlated with low cardiac index (r²=0.34, p=0.008).
- Reduced heart rate also showed a correlation with hepatic dysfunction (r²=0.18, p=0.07).
Conclusions:
- Hepatic dysfunction in Fontan survivors is linked to impaired cardiac output and heart rate.
- Maintaining optimal cardiac index is essential for preventing or mitigating long-term liver disease.
- Further research into hemodynamic optimization could improve outcomes for Fontan patients.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
